Renowned yoga guru Baba Ramdev, with millions of global followers, faces a significant setback as India's Supreme Court mandates an apology for deceptive claims regarding his company's products' curative abilities. The ruling comes after Ramdev touted Patanjali Ayurved's offerings as remedies for various ailments, including cancer, sparking controversy and legal action.

In videos on his Swami Ramdev YouTube channel, Ramdev promotes Patanjali products, advocating for their efficacy in treating ailments ranging from fever to cancer. Despite applause from his audience, the Supreme Court deemed these advertisements illegal under India's Drugs and Magic Remedies Act, which prohibits misleading claims about treatments for specific medical conditions.

Ramdev's refusal to comply with court orders led to further reprimands, including a scathing critique of regulatory authorities' inaction. However, Patanjali's history of controversies, from substandard products to false advertising, continues to raise concerns about its practices.

Despite regulatory challenges, Patanjali's popularity remains robust, bolstered by Ramdev's influential persona and alleged ties to India's ruling party, the BJP. As legal battles unfold, the saga underscores the complex intersection of traditional medicine, commercial interests, and regulatory oversight in India's healthcare landscape.